Beam Therapeutics Inc.
USD35.62
+0.67 (+1.90%)
CEO
John Evans
IPO Date
2020-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$34.83
Prev. Close
$34.95
Day Low
$33.62
Day High
$35.62
52W Low
$15.60
52W High
$36.88
Market Cap
$3.66B
Volume
0.63M
| -5.4 |
| 31 Dec 2023 | FY | 100.0% | -35.1% | -13.5% | -9.1% | 0.18 | 5.89 | -15.8 |
| 31 Dec 2022 | FY | -411.5% | -474.5% | -39.4% | -21.5% | 0.24 | 4.89 | -9.5 |
| 31 Dec 2021 | FY | -347.8% | -714.9% | -44.8% | -25.1% | 0.18 | 5.96 | -13.8 |
| 31 Dec 2020 | FY | -429812.5% | -810800.0% | -79.2% | -43.1% | 0.44 | 3.01 | -19.6 |
| 31 Dec 2019 | FY | -303338.9% | -435144.4% | -77.6% | -50.2% | 0.31 | 3.24 | -12.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -86.0% | -69.0% | 0.00 | 5.79 | -5.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 208.7% | -363.4% | -0.24 | 0.31 | -27.8 |
| 2.9 |
| 30 Sept 2025 | Q3 | -1031.9% | -1162.4% | -11.7% | -8.6% | 0.16 | 6.02 | -5.5 |
| 30 Jun 2025 | Q2 | -1102.0% | -1208.3% | -9.8% | -7.4% | 0.15 | 6.75 | -4.2 |
| 31 Mar 2025 | Q1 | -1222.8% | -1462.8% | -9.7% | -7.4% | 0.14 | 8.81 | -3.9 |
| 31 Dec 2024 | Q4 | -237.4% | -300.5% | -12.3% | -8.2% | 0.22 | 4.82 | -5.7 |
| 30 Sept 2024 | Q3 | -560.6% | -677.5% | -12.2% | -8.3% | 0.20 | 5.69 | -5.2 |
| 30 Jun 2024 | Q2 | 100.0% | -773.5% | -10.7% | -7.2% | 0.19 | 5.81 | -5.2 |
| 31 Mar 2024 | Q1 | -1044.6% | -1331.6% | -10.8% | -7.3% | 0.18 | 5.99 | -6.8 |
| 31 Dec 2023 | Q4 | 55.7% | 45.2% | 14.6% | 9.8% | 0.18 | 5.89 | 3.9 |